Role of warm ischemia on innate and adaptive responses in a preclinical renal auto-transplanted porcine model
© Rossard et al.; licensee BioMed Central Ltd. 2013
Received: 5 February 2013
Accepted: 13 May 2013
Published: 24 May 2013
Deceased after cardiac arrest donor are an additional source of kidney graft to overcome graft shortage. Deciphering the respective role of renal warm and cold ischemia is of pivotal interest in the transplantation process.
Using a preclinical pig model of renal auto-transplantation, we investigated the consequences of warm and cold ischemia on early innate and adaptive responses as well as graft outcome. Kidneys were subjected to either 60 min-warm ischemia (WI) or auto-transplanted after cold storage for 24 h at 4°C (CS), or both conditions combined (WI + CS). Renal function, immune response and cytokine expression, oxidative stress and cell death were investigated at 3 h, 3 and 7 days (H3, D3 and D7) after reperfusion. At 3 months, we focused on cell infiltration and tissue remodelling.
WI + CS induced a delayed graft function linked to higher tubular damage. Innate response occurred at D3 associated to a pro-oxidative milieu with a level dependent on the severity of ischemic injury whereas adaptive immune response occurred only at D7 mainly due to CS injuries and aggravated by WI. Graft cellular death was an early event detected at H3 and seems to be one of the first ischemia reperfusion injuries. These early injuries affect graft outcome on renal function, cells infiltration and fibrosis development.
The results indicate that the severe ischemic insult found in kidneys from deceased after cardiac arrest donor affects kidney outcome and promotes an uncontrolled deleterious innate and adaptive response not inhibited 3 months after reperfusion.
KeywordsIschemia-reperfusion Adaptive immune response Innate immune response Kidney transplantation Preclinical porcine model
In organ transplantation, graft shortage increases morbidity on dialysis; prolongs waiting times for adults and urges transplant physicians to accept new source of organs. Donor deceased after cardiac death (DCD), is an additional potential source of kidney graft which is more prone to severe ischemia reperfusion injury (IRI), primary non-function (PNF), and delayed graft function (DGF). In such donors, different ischemic conditions are associated such as warm ischemia (WI) and cold ischemia (CS) characterized respectively by an ischemic period at body temperature initiated by cardiac arrest ensuing a low and/or no blood flow and by a hypothermic preservation of kidneys. However, the respective role of WI and CS in transplantation conditions needs to be clarified to improve the use of graft from DCD, particularly from uncontrolled donors (class I, II and V of Maastricht classification). Consequently, researches into the mechanisms of WI, CS, and IRI are necessary to maximise the use of available donor pool and to minimise the PNF and DGF.
We and other have previously demonstrated that ischemia reperfusion sequence involved in renal auto-transplantation model induces inflammatory processes that are independent of the presence of allo-antigen [1, 2] and characterized by both innate and adaptive immune responses [2–4]. The pathophysiology of renal transplantation process involves a complex interplay among vascular, tubular, and inflammatory factors followed by a repair process or progressive fibrotic chronic kidney disease when it persists. The complex interplay between innate and adaptive immunity is still not completely understood and the chronological response related to the severity of graft lesions needs to be clarified. There is also a strong body of evidence that the consequences of IRI are identifiable in an increased acute rejection rate [5, 6].
In ischemic research, most experiments are carried out on rodents, but crucial prerequisites for the development of safe clinical protocols are needed through suitable large animal models like pig [7, 8]. Because the renal porcine anatomy and vascular bed are very similar with human, we used a porcine autologous renal transplant model. In addition, such model is an ideal situation for tolerance and allows focusing on IRI effects per se.
We hypothesize that the ischemic period is a crucial time point which is involved in the initial development of chronic graft injuries observed in the first months of reperfusion and that WI before transplantation induces an uncontrolled response which promotes a worst graft outcome. Thus, we propose to decipher the respective influences of CS and WI in a preclinical model of kidney transplantation on innate and adaptive response with a high degree of translation to the clinic, in an attempt to determine the chronology of lesion development and find the most discriminating markers and time windows to evaluate graft quality.
To this end, we have developed and validated different models to decipher WI and cold preservation injuries and the combined effect of these conditions enabling a step by step study [9–13]. The goal of the present work was to study the modulation of an ischemic preclinical model combining 60 min WI and 24 h CS followed by transplantation mimicking different clinical situations found in uncontrolled donors and particularly to decipher the innate and adaptive responses between WI and CS to easily manage the pharmacological approach.
Surgical procedure and experimental groups
We used a well controlled model of large white male pigs weighting 30 to 35 kg . The surgical and experimental protocols were performed in accordance with the institutional committee for the use and care of laboratory animals: COMETHEA (CEEA Poitou-Charentes, project reference numbers: CE2012-4 and CE2012-29). We determined 3 experimental conditions deciphering WI, CS and combination of WI and CS: 1. WI: 60 min in vivo ischemia by renal pedicle clamping without transplantation to mimic clinical situation of no-reflow (n = 12); 2. CS: kidney was removed, cold flushed, preserved at 4°C for 24 h in UW and autotransplanted (n = 12); 3. WI + CS: kidneys were subjected to both conditions to mimic DCD (n = 12). In each experimental group, the controlateral kidney was removed to mimic the graft nephron mass found in clinical situation. Reperfusion was studied at: 3 hours (H3), 3 and 7 days (D3 and D7), and 3 months (M3) with pig sacrifice at each time point. Native kidney is also used as control group.
Renal function determination
Urinary and plasma sodium for fractional excretion of sodium (FeNa+) evaluation were determined at H0, H3, D3 and D7. Plasma creatinin was measured at H0, H3, D3 and D7 and M3 after reperfusion and urinary protein excretion was determined at M3 after reperfusion using an automated chemistry analyzer (Modular, Roche Diagnostics, France).
Histochemical and immunohistochemical study
Histochemistry for tubular atrophy and Red Sirius staining on cortex samples was performed as previously described . Immunohistochemical studies were performed using anti-CD3 (Cell marque Corporation, USA), and anti-ED1 (AbD Serotec, USA). All sections were examined under blind conditions by a pathologist. Apoptotic signals were characterized by immunostaining using anti-cleaved caspase 3 antibodies (R&D System, USA).
Real-time quantitative PCR
We used RNA extraction kit (Qiagen, France). Genomic DNA was removed using DNA-free kit (Applied Biosystems, USA) and first-strand reverse transcription was performed. Real-Time PCR assays were performed on an ABI Prism 7300 (Applied Biosystems) with porcine primers (Additional file 1: Table S1).
Western blot analysis
Western Blotting was carried out according to standard protocols  using specific antibodies against superoxide dismutase-1, transforming growth factor β, pro-matrix metalloproteinase-2, tissue plasminogen activator (SOD-1, TGFβ, pro-MMP-2, tPa, Santa Cruz, USA), pSmad3 (pSmad3, Cell signalling, France), monocyte chemoattractive protein-1 (MCP-1, Clinisciences, France), bone morphogenetic protein-7 (BMP-7, AbD Serotec, France), plasminogen activator inhibitor-1 (PAI-1, BD-Bioscience, USA) and loading control: glyceraldehyde 3-phosphate dehydrogenase or β actin (GAPDH, βactin, Sigma Aldrich, France).
Values are reported as the mean ± SEM. Statistical differences between groups were calculated using ANOVA followed by the Student-Newman-Keuls test or Kruskal Wallis test for multiple comparison analysis. Correlation analysis was performed with NCSS software (NCSS LLC, USA), r2 is displayed and significance established with the Spearman rank test. p < 0.05 was considered as significant.
Severe IRI affects early renal function in preclinical model
Renal function evaluation by systemic and urinary parameters levels before, at H3, D3 , D7 and M3 after reperfusion in warm ischemia (WI), cold storage (CS), warm ischemia + cold storage (WI + CS) groups
88 ± 5
142 ± 3
435 ± 3
180 ± 8
122 ± 2
86 ± 5
337 ± 5 ‡
1031 ± 34 ‡
169 ± 8
147 ± 4 ‡
WI + CS group
85 ± 2
412 ± 10 ‡ º
1823 ± 108 ‡ º
447 ± 70 ‡ º
335 ± 15 ‡ º
Fractional excretion of sodium (FeNa+,%)
0.18 ± 0.01
5.79 ± 0.38
2.93 ± 0.22
0.22 ± 0.02
18.67 ± 1.20‡
7.29 ± 0.31‡
WI + CS group
0.17 ± 0.02
12.73 ± 0.21‡º
0.50 ± 0.15
2.80 ± 0.50 ‡
WI + CS group
4.10 ± 0.80 ‡ º
Severe ischemia induces a pro-oxidative milieu and cell death
The apoptotic and necrotic processes are early associated with ischemic conditions. Tubular necrosis was early observed in all studied group at H3 and maintained at D7 compared to control (Figure 1c). The WI + CS group was characterized by early high cleaved caspase 3 staining; less marked in WI and CS groups (Figure 1d). At D7, CS and WI + CS groups exhibited a high expression of cleaved caspase 3 in contrast to the basal values observed in WI group (Figure 1d).
Early innate and adaptive immunity depend on the severity of IRI
ED1+ cells infiltration started early at D3 with higher intensity in CS and WI + CS. At D7, this process indicated potential macrophages phagocytosis gradually developing in relation with the severity of IRI [18, 19] (Figure 2f). In turn, a drastic CD3+ lymphocyte invasion was recorded in CS groups with a higher degree in WI + CS group only at D7 in contrast to baseline level in WI (Figure 2f).
Warm ischemia increases cold storage-induced immune response, tubular injury and fibrotic response in the long term
Adaptive response affects early and chronic graft function
The worldwide shortage of standard brain dead donors has revived the use of kidneys from DCD. Therefore, with the required framework, DCD kidney transplant programs were reintroduced at the turn of the century. Experimental approach clearly defined that ischemic period is a crucial time which affects organ outcome . Since 1994, we developed several pre-clinical pig models mimicking clinical situations. The aim of this study was to decipher the deleterious effects induced in organ from DCD conditions to improve and adapt graft preservation. A previous study described the effect of both WI and CS in ex-vivo porcine model without a separated analysis of each condition . In addition in this report, the renal function was measured over a period of 3 hours. In our study, three types of IRI and their respective roles were compared: WI accompanied by no-reflow condition (shock, cardiac or aortic surgery or asystolic time) and CS involved in transplantation process, potentially preceded by WI in DCD conditions. In these conditions, the inflammatory and immune response which are key processes involved in repair as well as in chronic kidney fibrosis were studied at 3 hr, 3 days and 7 days for early stage after reperfusion and also at 3 months .
During the first week of reperfusion, renal function in groups exposed to CS was more affected than in WI group. Our auto-transplant setting is an emblematic situation of tolerance, in which IRI per se can break this tolerance and destines the graft to a degraded chronic outcome. The initiation of immune response appears in the early hours in an identical fashion in all conditions; however it is maintained and will expand in proportion to the level of injury, supporting the concept of immunity is a solid discriminatory tool between damage intensities. Interestingly, we correlated the number of adaptive immune cells recruited with plasma creatinin levels at the end of the first week of reperfusion underlining a direct relationship between the intensity of inflammatory process and pejorative graft outcome.
Oxidative stress and apoptosis are two major components of IRI, both closely associated to the inflammatory process . We demonstrated that CS combined or not with WI induced an overexpression of NADPH oxidase enzyme subunits during the first week of reperfusion in contrast to WI alone. This complex may participate in the superoxide anion production by inflammatory cells infiltrating the graft, or directly from the injured tissue. This pro-oxidative milieu was accentuated by a decreased expression of the major antioxidant enzymes: SODs already reported in a rodent model . These results indicate that severe ischemic conditions induce an early pro-oxidative microenvironment and that D3 is a critical time point to evaluate the red/ox balance. Apoptosis is also known to be an important response to ischemic injury . Our results indicate an early activation of the apoptotic process few hours after ischemia. The high level of cleaved caspase 3 staining at H3 and the return to basal values at D7 in WI group suggests an early transitory apoptotic process. However, the high level of injury in WI + CS group at H3 was associated with a high staining level but limited in CS group. On the other hand, at D7 this expression was similar in both CS groups, highlighting the need for early evaluation of such markers, since along with oxidative stress, this pathway is only discriminant in the early days of reperfusion. In these conditions, apoptosis markers could be primarily detected in tubular cells as previously described in human cadaveric kidney allograft . Taken together, these results support that ischemia condition and duration  could influence the level and the localisation of the apoptotic process.
Our study investigates the chronological development of early immunity in various preclinical ischemic conditions. Endothelial activation, a prerequisite in the initial recruitment of leukocytes to the site of injury, is a key of innate immunity response initiation commonly assessed by vascular endothelium markers expression such as selectin adhesion molecules. In our conditions, P-selectin mRNA expression was increased early after reperfusion (H3) in CS and WI + CS groups then reached control values at D7. However, WI did not affect this expression. Early immunity could be partially mediated by Damage Associated Molecular Pattern molecules (DAMPs) which bind the TLRs [16, 28, 29]. These DAMPs are released by cells that have been damaged by IR and thus closely associated to oxidative stress, apoptosis and necrosis [30, 31]. TLRs constitute an integral part of the innate immune response and play a pivotal role in IRI, though the role of each receptor is still unclear . The stimulated-TLRs pathway induces the production of pro-inflammatory cytokines such as IL-1β, TNFα, IL-6, IL-8 as well as expression of cell adhesion molecules like VCAM-1 on endothelial cells . In a recent study using deficient TLR4 mice, Pulskens et al. show that TLR4 initiates an exaggerated pro-inflammatory response upon renal IRI and subsequently controls the induction of an innate immune response . In our study, TLR2 expression followed the level of renal injury, particularly after D3. TLR4 overexpression was found in CS and WI + CS, but was not significantly different between both groups. Thus, TLR4 expression appears due to cold ischemic injury while TLR2 is a more discriminant marker of ischemic stress level. MCP-1 was significantly overexpressed in WI + CS from D3 supporting that the degree of injury seems to modulate the MCP-1 response. MCP-1 recruits monocytes and dendritic cells to the sites of tissue injury and inflammation. In addition, DAMPs are known to stimulate IL-1β secretion from the NLRP3 (NOD-like receptors Protein 3) inflammasome inducing pro-inflammatory cytokines production and immune cells invasion . As IL-1β, IL-6 could be produced by macrophages to stimulate immune response in damaged tissue leading to expand inflammation. Interestingly, we observed an IL1Rn mRNA (gene encoded to Interleukin-1 receptor antagonist) increased expression at D3 which could be appearing in response to IL-1β production. We reported an IL-10 mRNA over-expression by high intensity of IRI up to one week after reperfusion. As previously described, IL-10 could be a protecting agent against renal IRI decreasing TNFα expression and reactive oxygen species production . Our observed IL-10 levels could be linked to autologous immune response induced by CS as our results showed no differences between CS and WI + CS. In our results, this alarming environment, stimulated in the WI + CS condition was characterized by an increase of TLR2 and TLR4 mRNA supporting a DAMPs pathway, stimulating an upregulation from D3 of MCP1 and macrophages invasion.
The originality of this study was the graft follow-up during the first three months after transplantation. In accordance to the findings of the first week of reperfusion, we observed a deleterious effect of WI when is combined with CS. Indeed, the difference at D3 in term of renal function in each group was also observed at 3 months. As previously described in our DCD mimicking model , associating WI + CS, we observed an inflammatory response characterized by endothelial activation remaining until three months after reperfusion with an increase of MCP-1, and VCAM-1 expressions. These results were supported by lymphocytes and monocytes recruitment already described in this model seven days after reperfusion and maintained 3 months later. As these parameters did not reach statistical differences compared to control in WI or CS groups, these results highlight the direct relationship between the intensity of IR and chronic outcome. Above a certain degree of injury, specific pathological processes are rendered irreversible and will unavoidably lead to chronic failure.
Accordingly, we observed a level of tubular atrophy and fibrosis directly dependent on the severity of ischemia three months before. We underlined that WI alone also promotes fibrosis development although the inflammatory response was not present suggesting a stable process. As expected, CS group exhibited a collagen expression level between WI and WI + CS. Moreover, the development of renal fibrosis is still ongoing in WI + CS group, as indicated by profibrotic pathways activation analysis. While in WI or CS group they appear inhibited or reduced, we showed a trend towards increased for TGFβ and a significant rise of its first downstream mediator pSmad3 in WI + CS, indicate a maintain production of collagen and a progression of renal fibrosis accentuated by MMP-2 decrease expression supporting a less extracellular matrix degradation. In addition, these three parameters are not affecting three months after reperfusion by WI or CS conditions, conversely to BMP-7. In fact, CS group exhibited a high expression of BMP-7 in favour to a reduction of TGFβ pathway activation and an inhibition of collagen synthesis . Plasminogen pathway is also involved in extracellular matrix homeostasis and subsequent fibrosis development . We observed an upper expression of PAI-1 in ischemic groups which attained significant difference in WI + CS group which is associated to a down-expression of tPA compared to WI or CS groups. In these conditions, as BMP-7, the tPA expression is increased related to control value indicating a high extracellular matrix degradation which could explain, in part, the minor intensity of red Sirius staining in these groups.
In conclusion, the severity of ischemic injuries induced by WI in transplantation process found in kidneys from DCD has a crucial impact in early immune reactivity, graft recovery and outcome, suggesting to intensify follow up in case of DCD organs. Recently, we reported that cold preservation time in DCD conditions is an interesting therapeutic window giving the opportunity to treat the graft without systemic effect especially by pulsatile perfusion, oxygenated preservation or with pharmacological molecules . The complexity of the injury exposed herein strengthens the need for adapted animal models able to evaluate varying degrees of injury and new protocols in clinic-like conditions. Such translational models offer the possibility to study various aspects related to kidney preservation and to develop accurate protocols for organ management from DCD easily applicable in clinical situation.
Cold storage for 24 h at 4°C
- WI + CS:
Warm ischemia combined with cold storage for 24 h at 4°C
Donor deceased after cardiac death
Acute kidney injury
Fractional excretion of sodium
Transforming growth factor β
Tissue plasminogen activator
Monocyte chemoattractive protein-1
Bone morphogenetic protein-7
Plasminogen activator inhibitor-1
Glyceraldehyde 3-phosphate dehydrogenase
- NADPH oxidase:
Nicotinamide adenine dinucleotide phosphate oxidase
The interleukin-1 receptor antagonist
Damage associated molecular pattern molecules
NOD-like receptors protein 3.
We are grateful to Pr Michel Eugene for his guidance and advices. We also thank Severine Deretz and William Hebrard (Département de Génétique Animale, INRA, Surgères), Sandrine Joffrion and Virginie Ameteau for their excellent technical support. This work was supported by grants from the Ministère Français de l’Enseignement Supérieur et de la Recherche, Conseil Régional Poitou-Charentes, University of Poitiers, Banque Tarneaud, University Hospital of Poitiers, Institut National de Recherche Agronomique and French Society of Organ Transplantation.
- Salahudeen AK, Haider N, May W: Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney Int. 2004, 65: 713-718. 10.1111/j.1523-1755.2004.00416.x.View ArticlePubMedGoogle Scholar
- Hauet T, Goujon JM, Baumert H, Petit I, Carretier M, Eugene M, Vandewalle A: Polyethylene glycol reduces the inflammatory injury due to cold ischemia/reperfusion in autotransplanted pig kidneys. Kidney Int. 2002, 62: 654-667. 10.1046/j.1523-1755.2002.00473.x.View ArticlePubMedGoogle Scholar
- Bon D, Chatauret N, Giraud S, Thuillier R, Favreau F, Hauet T: New strategies to optimize kidney recovery and preservation in transplantation. Nat Rev Nephrol. 2012, 8: 339-347. 10.1038/nrneph.2012.83.View ArticlePubMedGoogle Scholar
- Bonventre JV: Pathophysiology of AKI: injury and normal and abnormal repair. Contrib Nephrol. 2010, 165: 9-17.View ArticlePubMedGoogle Scholar
- van der Vliet JA, Warle MC: The need to reduce cold ischemia time in kidney transplantation. Curr Opin Organ Transplant. 2013, 18: 174-178. 10.1097/MOT.0b013e32835e2a08.View ArticlePubMedGoogle Scholar
- Mikhalski D, Wissing KM, Ghisdal L, Broeders N, Touly M, Hoang AD, Loi P, Mboti F, Donckier V, Vereerstraeten P, Abramowicz D: Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Transplantation. 2008, 85: S3-S9. 10.1097/TP.0b013e318169c29e.View ArticlePubMedGoogle Scholar
- Jochmans I, Lerut E, Heedfeld V, Wylin T, Pirenne J, Monbaliu D: Reproducible model for kidney autotransplantation in pigs. Transplant Proc. 2009, 41: 3417-3421. 10.1016/j.transproceed.2009.09.024.View ArticlePubMedGoogle Scholar
- Giraud S, Favreau F, Chatauret N, Thuillier R, Maiga S, Hauet T: Contribution of large pig for renal ischemia-reperfusion and transplantation studies: the preclinical model. J Biomed Biotechnol. 2011, 2011: 532127-PubMed CentralView ArticlePubMedGoogle Scholar
- Jayle C, Faure JP, Thuillier R, Goujon JM, Richer JP, Hauet T: Influence of nephron mass and a phosphorylated 38 mitogen-activated protein kinase inhibitor on the development of early and long-term injury after renal warm ischaemia. Br J Surg. 2009, 96: 799-808. 10.1002/bjs.6589.View ArticlePubMedGoogle Scholar
- Cau J, Favreau F, Zhang K, Febrer G, de la Motte GR, Ricco JB, Goujon JM, Hauet T: FR167653 improves renal recovery and decreases inflammation and fibrosis after renal ischemia reperfusion injury. J Vasc Surg. 2009, 49: 728-740. 10.1016/j.jvs.2008.09.056.View ArticlePubMedGoogle Scholar
- Doucet C, Zhang K, Desurmont T, Hebrard W, Scepi M, Nadeau C, Cau J, Leyre P, Febrer G, Carretier M: Influence of warm ischemia time on peripheral-type benzodiazepine receptor: a new aspect of the role of mitochondria. Nephron Exp Nephrol. 2007, 107: e1-e11. 10.1159/000105139.View ArticlePubMedGoogle Scholar
- Jayle C, Favreau F, Zhang K, Doucet C, Goujon JM, Hebrard W, Carretier M, Eugene M, Mauco G, Tillement JP, Hauet T: Comparison of protective effects of trimetazidine against experimental warm ischemia of different durations: early and long-term effects in a pig kidney model. Am J Physiol Renal Physiol. 2007, 292: F1082-F1093.View ArticlePubMedGoogle Scholar
- Favreau F, Thuillier R, Cau J, Milin S, Manguy E, Mauco G, Zhu X, Lerman LO, Hauet T: Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model. Am J Transplant. 2010, 10: 30-39. 10.1111/j.1600-6143.2009.02924.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Chade AR, Rodriguez-Porcel M, Grande JP, Zhu X, Sica V, Napoli C, Sawamura T, Textor SC, Lerman A, Lerman LO: Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol. 2003, 23: 1295-1301. 10.1161/01.ATV.0000077477.40824.52.View ArticlePubMedGoogle Scholar
- Loukogeorgakis SP, van den Berg MJ, Sofat R, Nitsch D, Charakida M, Haiyee B, de Groot E, MacAllister RJ, Kuijpers TW, Deanfield JE: Role of NADPH oxidase in endothelial ischemia/reperfusion injury in humans. Circulation. 2010, 121: 2310-2316. 10.1161/CIRCULATIONAHA.108.814731.View ArticlePubMedGoogle Scholar
- Arslan F, Keogh B, McGuirk P, Parker AE: TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm. 2010, 2010 704202: 1-8.View ArticleGoogle Scholar
- Pulskens WP, Teske GJ, Butter LM, Roelofs JJ, van der Poll T, Florquin S, Leemans JC: Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS One. 2008, 3: e3596-10.1371/journal.pone.0003596.PubMed CentralView ArticlePubMedGoogle Scholar
- Jang HR, Ko GJ, Wasowska BA, Rabb H: The interaction between ischemia-reperfusion and immune responses in the kidney. J Mol Med. 2009, 87: 859-864. 10.1007/s00109-009-0491-y.View ArticlePubMedGoogle Scholar
- Jang HR, Rabb H: The innate immune response in ischemic acute kidney injury. Clin Immunol. 2009, 130: 41-50. 10.1016/j.clim.2008.08.016.PubMed CentralView ArticlePubMedGoogle Scholar
- Eltzschig HK, Eckle T: Ischemia and reperfusion–from mechanism to translation. Nat Med. 2011, 17: 1391-1401. 10.1038/nm.2507.View ArticlePubMedGoogle Scholar
- Hosgood SA, Bagul A, Yang B, Nicholson ML: The relative effects of warm and cold ischemic injury in an experimental model of nonheartbeating donor kidneys. Transplantation. 2008, 85: 88-92. 10.1097/01.tp.0000296055.76452.1b.View ArticlePubMedGoogle Scholar
- Wynn TA: Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest. 2007, 117: 524-529. 10.1172/JCI31487.PubMed CentralView ArticlePubMedGoogle Scholar
- Nakagawa T, Kang DH, Ohashi R, Suga S, Herrera-Acosta J, Rodriguez-Iturbe B, Johnson RJ: Tubulointerstitial disease: role of ischemia and microvascular disease. Curr Opin Nephrol Hypertens. 2003, 12: 233-241. 10.1097/00041552-200305000-00003.View ArticlePubMedGoogle Scholar
- Liang HL, Hilton G, Mortensen J, Regner K, Johnson CP, Nilakantan V: MnTMPyP, a cell-permeant SOD mimetic, reduces oxidative stress and apoptosis following renal ischemia-reperfusion. Am J Physiol Renal Physiol. 2009, 296: F266-F276.PubMed CentralView ArticlePubMedGoogle Scholar
- Meldrum KK, Hile K, Meldrum DR, Crone JA, Gearhart JP, Burnett AL: Simulated ischemia induces renal tubular cell apoptosis through a nuclear factor-kappaB dependent mechanism. J Urol. 2002, 168: 248-252. 10.1016/S0022-5347(05)64902-6.View ArticlePubMedGoogle Scholar
- Castaneda MP, Swiatecka-Urban A, Mitsnefes MM, Feuerstein D, Kaskel FJ, Tellis V, Devarajan P: Activation of mitochondrial apoptotic pathways in human renal allografts after ischemiareperfusion injury. Transplantation. 2003, 76: 50-54. 10.1097/01.TP.0000069835.95442.9F.View ArticlePubMedGoogle Scholar
- Burns AT, Davies DR, McLaren AJ, Cerundolo L, Morris PJ, Fuggle SV: Apoptosis in ischemia/reperfusion injury of human renal allografts. Transplantation. 1998, 66: 872-876. 10.1097/00007890-199810150-00010.View ArticlePubMedGoogle Scholar
- Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, Kirschning CJ, Akira S, van der Poll T, Weening JJ, Florquin S: Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest. 2005, 115: 2894-2903. 10.1172/JCI22832.PubMed CentralView ArticlePubMedGoogle Scholar
- Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF, Chadban SJ: TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest. 2007, 117: 2847-2859. 10.1172/JCI31008.PubMed CentralView ArticlePubMedGoogle Scholar
- Thurman JM: Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol. 2007, 123: 7-13. 10.1016/j.clim.2006.09.008.PubMed CentralView ArticlePubMedGoogle Scholar
- Yamada Y, Fujii T, Ishijima R, Tachibana H, Yokoue N, Takasawa R, Tanuma S: DR396, an apoptotic DNase gamma inhibitor, attenuates high mobility group box 1 release from apoptotic cells. Bioorg Med Chem. 2011, 19: 168-171. 10.1016/j.bmc.2010.11.037.View ArticlePubMedGoogle Scholar
- Chang WJ, Toledo-Pereyra LH: Toll-like receptor signaling in liver ischemia and reperfusion. J Invest Surg. 2012, 25: 271-277. 10.3109/08941939.2012.687802.View ArticlePubMedGoogle Scholar
- Wu H, Ma J, Wang P, Corpuz TM, Panchapakesan U, Wyburn KR, Chadban SJ: HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol. 2010, 21: 1878-1890. 10.1681/ASN.2009101048.PubMed CentralView ArticlePubMedGoogle Scholar
- Wanderer AA: Rationale and timeliness for IL-1beta-targeted therapy to reduce allogeneic organ injury at procurement and to diminish risk of rejection after transplantation. Clin Transplant. 2010, 24: 307-311.View ArticlePubMedGoogle Scholar
- Deng J, Kohda Y, Chiao H, Wang Y, Hu X, Hewitt SM, Miyaji T, McLeroy P, Nibhanupudy B, Li S, Star RA: Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int. 2001, 60: 2118-2128. 10.1046/j.1523-1755.2001.00043.x.View ArticlePubMedGoogle Scholar
- Thuillier R, Favreau F, Celhay O, Macchi L, Milin S, Hauet T: Thrombin inhibition during kidney ischemia-reperfusion reduces chronic graft inflammation and tubular atrophy. Transplantation. 2010, 90: 612-621.View ArticlePubMedGoogle Scholar
- Boor P, Floege J: Chronic kidney disease growth factors in renal fibrosis. Clin Exp Pharmacol Physiol. 2011, 38: 441-450. 10.1111/j.1440-1681.2011.05487.x.View ArticlePubMedGoogle Scholar
- Grandaliano G, Di Paolo S, Monno R, Stallone G, Ranieri E, Pontrelli P, Gesualdo L, Schena FP: Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy: the role of coagulation and fibrinolysis in renal graft fibrosis. Transplantation. 2001, 72: 1437-1443. 10.1097/00007890-200110270-00018.View ArticlePubMedGoogle Scholar
- Chatauret N, Thuillier R, Hauet T: Preservation strategies to reduce ischemic injury in kidney transplantation: pharmacological and genetic approaches. Curr Opin Organ Transplant. 2011, 16: 180-187. 10.1097/MOT.0b013e3283446b1d.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.